Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland

被引:7
|
作者
Clarke, Stuart C.
Jefferies, Johanna M. C.
Smith, Andrew J.
McMenamin, Jim
Mitchell, Timothy J.
Edwards, Giles F. S.
机构
[1] Stobhill Gen Hosp, Scottish Meningococcus & Pneumococcus Reference L, Glasgow G21 3UW, Lanark, Scotland
[2] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
[3] Portsmouth City Teaching PCT, Portsmouth PO3 6DP, Hants, England
[4] Glasgow Dent Hosp & Sch, Glasgow G2 3JZ, Lanark, Scotland
[5] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland
关键词
D O I
10.1099/jmm.0.46550-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study aimed to determine the serotypes and sequence types (STs) of pneumococci causing paediatric invasive disease in Scotland prior to the introduction of pneumococcal conjugate vaccines (PCVs). All invasive pneumococci isolated between 2000 and 2004 from children aged less than 5 years in Scotland were used. The isolates were characterized by serotyping and multi-locus sequence typing. Two hundred and seventeen pneumococci were characterized into 22 different serogroups/types, the most common, in rank order, being 14, 19F, 6B, 18C, 23F, 9V, 4, 1, 19A and 6A. They were further genotyped into 77 different STs, the three most common being 9, 162 and 176. Common serotypes possessed multiple STs, but pneumococci of a particular clone were mostly associated with a particular serotype. The seven most common serotypes are included in the 7-valent polysaccharide conjugate vaccine (PCV7). Serotype coverage for PCV7 was 76.5 % in those aged less than 5 years but increased to 88.9 % for those aged 1 year. The introduction of PCV7 into the childhood immunization schedule would reduce the burden of pneumococcal disease in children, although continued surveillance of invasive pneumococcal disease will be required before, during and after the introduction of PCVs.
引用
收藏
页码:1079 / 1084
页数:6
相关论文
共 50 条
  • [21] UNDERLYING CONDITIONS IN CHILDREN WITH INVASIVE PNEUMOCOCCAL DISEASE IN THE CONJUGATE VACCINE ERA
    Hsu, Katherine K.
    Shea, Kimberly M.
    Stevenson, Abbie E.
    Pelton, Stephen I.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (03) : 251 - 253
  • [22] Geographic Variation in Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccine Introduction in the United States
    Rosen, Jennifer B.
    Thomas, Ann R.
    Lexau, Catherine A.
    Reingold, Art
    Hadler, Jim L.
    Harrison, Lee H.
    Bennett, Nancy M.
    Schaffner, William
    Farley, Monica M.
    Beall, Bernard W.
    Moore, Matt R.
    CLINICAL INFECTIOUS DISEASES, 2011, 53 (02) : 137 - 143
  • [23] The conjugate vaccine and invasive pneumococcal disease - Reply
    Whitney, CG
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07): : 715 - 716
  • [24] Effect of the introduction of the pneumococcal conjugate vaccine on invasive disease produced by Streptococcus pneumoniae
    Cercenado, E.
    Cuevas, O.
    Fenoll, A.
    Marin, M.
    Vicioso, D.
    Bouza, E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S294 - S294
  • [25] Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North America
    Palmu, Arto A.
    De Wals, Philippe
    Toropainen, Maija
    Ladhani, Shamez N.
    Deceuninck, Genevieve
    Knol, Mirjam J.
    Sanders, Elisabeth A. M.
    Miller, Elizabeth
    VACCINE, 2021, 39 (11) : 1551 - 1555
  • [26] Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease
    Palmu, Arto A.
    Kilpi, Terhi M.
    Rinta-Kokko, Hanna
    Nohynek, Hanna
    Toropainen, Maija
    Nuorti, J. Pekka
    Jokinen, Jukka
    PEDIATRICS, 2015, 136 (01) : E22 - E27
  • [27] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [28] PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
    Chapman, Timothy J.
    Olarte, Liset
    Dbaibo, Ghassan
    Houston, Avril Melissa
    Tamms, Gretchen
    Lupinacci, Robert
    Feemster, Kristen
    Buchwald, Ulrike K.
    Banniettis, Natalie
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 137 - 147
  • [29] Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
    Alexandrova Nikolova, Kristiana
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2024, 12 (02)
  • [30] Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use
    Pilishvili, Tamar
    Zell, Elizabeth R.
    Farley, Monica M.
    Schaffner, William
    Lynfield, Ruth
    Nyquist, Ann-Christine
    Vazquez, Marietta
    Bennett, Nancy M.
    Reingold, Arthur
    Thomas, Ann
    Jackson, Delois
    Schuchat, Anne
    Whitney, Cynthia G.
    PEDIATRICS, 2010, 126 (01) : E9 - E17